Future studies exploring the individual contributions of the different tau isoforms to the elevated phosphorylated tau levels in blood and the protective mechanisms that prevent aggregation could lead to novel interventions that replicate these developmental conditions in Alzheimer’s disease. The gene discussed is MAPT; the disease is Alzheimer disease.